Merging the Art and Science of Managing nOH in Clinical Practice

Slides:



Advertisements
Similar presentations
INTERACTIVE QUESTIONS. Discussion Question What is central sensitization/ dysfunctional pain? Pathophysiology.
Advertisements

Multimodal Management of Opioid-Induced Constipation
Upfront Combination Therapy vs Step-Up Approach for PAH:
The Patient Experience With Systemic Lupus Erythematosus
Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.
Glaucoma.
HIV-Associated Weight Loss and Wasting
Assessing COPD in Primary Care
COPD.
Systemic Lupus Erythematosus
COPD by the Guidelines.
Primary Care Challenges in Depression - To Treat or Refer?
Update on the Diagnosis and Management of CTEPH in Latin America
Why Gene Therapy for Hemophilia?
Treatment Strategies in Mild to Moderate COPD
Making Decisions With Your Osteoarthritis Patients
A Fresh Look at Dry Eye.
This talk will follow the topical structure suggested by the ABP:
Does One Size Fit All in Obesity Management?
Progression After Cancer Immunotherapy in Advanced NSCLC
The Patient Journey to Remission in MDD: A Collaborative Approach
Reducing Postoperative Ileus
Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.
The Latest Data on Oral Prostacyclin Therapy in PAH
Epidemiology Venous Pathophysiology Etiology.
Dual Bronchodilation in COPD: From Clinical Trial Evidence to Clinical Practice.
New Insights Into Neurogenic Orthostatic Hypotension
Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Screening and Diagnosing Postpartum Depression
When Would You Use Single Inhaler Triple Therapy in COPD?
Follow-Up of the Patient After PE
Improving Risk Assessment and Early Diagnosis in PAH
Multidisciplinary Perspectives on Interstitial Lung Diseases
Discussion and Concluding Remarks
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
Immunotherapy for cSCC
Pseudobulbar Affect or Psychiatric Condition?
Diagnosing Focal Epilepsy: A Clinical Case
Updates in Neurogenic Orthostatic Hypotension
Introduction. Exploring Strategies for Recognition and Management of Lower Limb Spasticity in Children.
Best Practices in the Clinical Management of Motor Symptoms Associated With Huntington Disease.
Best Practices in the Identification and Management of Alzheimer Agitation.
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
When Is Biologic Therapy Appropriate for HS?
Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.
Navigating Treatment Options in PAH
When to Start and What to Use
When Is Intrathecal Drug Delivery Appropriate?
Treatment-Resistant Schizophrenia
Case 1 Presentation Case 1 (cont) Assessment and Recommendations.
Guide to Atopic Dermatitis
Management of Systemic Lupus Erythematosus
EGPA.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient Questions and Expert Answers in Psoriasis:
What's New in PAH?.
Critical Decision Points in Insomnia
Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.
Incorporating Prostacyclins Into Practice
When Is Intrathecal Drug Delivery Appropriate?
Clinical Comparisons in CTEPH
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Tardive Dyskinesia 101.
The Building Blocks of Homocystinuria and Homocysteinemia Management
What's New in PAH?.
Foundations of Asthma.
Shared Decision Making in MS
Advances in Portopulmonary Hypertension
Motor Fluctuations in PD
Presentation transcript:

Merging the Art and Science of Managing nOH in Clinical Practice

Definitions of OH and nOH

Pathophysiology of OH and nOH

Case Study

Patients in 5 Categories at Higher Risk for OH or nOH

Screening Questions for Suspected OH or nOH

How to Diagnose OH Features Suggestive of nOH

Diagnosis of nOH in Individuals Who Screen Positive for OH If the Diagnosis is OH and not nOH

Common Medications That May Cause OH or Exacerbate the Symptoms of nOH

Consensus Panel Recommendations Supine Hypertension and nOH

Treatment Algorithm for nOH

Treating nOH – Step 1 Review and Adjust Current Medications

Treating nOH – Step 2 Nonpharmacologic Measures

Treating nOH – Step 2 Nonpharmacologic Measures (cont)

Treating nOH – Step 2 Nonpharmacologic Measures (cont)

Treating nOH – Step 3 Initial Pharmacologic Treatment

Pharmacologic Options Fludrocortisone

Pharmacologic Options Midodrine

Pharmacologic Options Droxidopa

Pharmacologic Options Pyridostigmine

Mechanisms of Action of Investigational Therapies

Assessing nOH Treatment Success

Concluding Remarks

Abbreviations